VIP - vasoactive intestinal peptide Gene
Species: Macaca mulatta
Gene Type: protein coding
Gene ID: 703566
VIP Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001260752.1 | NP_001247681.1 | vasoactive intestinal peptide precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
vasoactive intestinal peptide |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P0012 | Aviptadil | Inhibitor | 99.95% | Unkown |
| HY-P0012A | Aviptadil acetate | Inhibitor | 99.87% | Unkown |
Clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-103019B | (-)-Enitociclib | 99.85% | Phase 1 | |
| HY-164429 | VIP236 | / | Phase 1 | |
| HY-103019BR | (-)-Enitociclib (Standard) | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(42)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P0221 | PACAP (1-38), human, ovine, rat | Inducer | 99.99% | Unkown |
| HY-103019 | Enitociclib | 99.89% | Unkown | |
| HY-P0220A | PACAP (6-38), human, ovine, rat TFA | 99.89% | Unkown | |
| HY-P5005 | VIPhyb | 99.82% | Unkown | |
| HY-P0221C | PACAP (1-38) free acid | 99.94% | Unkown | |
| HY-P1023 | VIP(6-28)(human, rat, porcine, bovine) | Antagonist | 98.09% | Unkown |
| HY-P0220 | PACAP (6-38), human, ovine, rat | 99.98% | Unkown | |
| HY-103019A | (±)-Enitociclib | 99.23% | Unkown | |
| HY-P4776 | Acetyl-(D-Phe2,Lys15,Arg16,Leu27)-VIP (1-7)-GRF (8-27) | Antagonist | 98.01% | Unkown |
| HY-P4127A | M65 TFA | Inhibitor | 99.98% | Unkown |
| HY-P4195A | [K15,R16,L27]VIP(1-7)/GRF(8-27) acetate | Agonist | 99.50% | Unkown |
| HY-P1159A | [D-p-Cl-Phe6,Leu17]-VIP TFA | 98.16% | Unkown | |
| HY-P1015 | VIP(Guinea pig) | Ligand | 98.66% | Unkown |
| HY-P11288A | ANT308 TFA | 99.57% | Unkown | |
| HY-P10768A | Ro 25-1553 TFA | Agonist | 99.17% | Unkown |
| HY-P3117 | PACAP (6-27) (human, ovine, rat) | Antagonist | 99.36% | Unkown |
| HY-P10948A | CS-VIP 8 hydrochloride | Inhibitor | 96.04% | Unkown |
| HY-P10768B | Ro 25-1553 acetate | Agonist | 98.17% | Unkown |
| HY-P4195 | [K15,R16,L27]VIP(1-7)/GRF(8-27) | Agonist | / | Unkown |
| HY-172680 | DSPE-PEG1000-VIP | / | Unkown | |
| HY-172681 | DSPE-PEG2000-VIP | / | Unkown | |
| HY-172681A | DSPE-PEG3400-VIP | / | Unkown | |
| HY-172682 | DSPE-PEG5000-VIP | / | Unkown | |
| HY-P0211 | [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human) | Antagonist | / | Unkown |
| HY-P0221A | PACAP (1-38), human, ovine, rat TFA | Inducer | / | Unkown |
| HY-P0221B | PACAP (1-38) free acid TFA | / | Unkown | |
| HY-P1015A | VIP(Guinea pig) TFA | Ligand | / | Unkown |
| HY-P10768 | Ro 25-1553 | Agonist | / | Unkown |
| HY-P10948 | CS-VIP 8 | Inhibitor | / | Unkown |
| HY-P11288 | ANT308 | / | Unkown | |
| HY-P1158 | [Ala2,8,9,11,19,22,24,25,27,28]-VIP | / | Unkown | |
| HY-P1159 | [D-p-Cl-Phe6,Leu17]-VIP | Antagonist | / | Unkown |
| HY-P1767 | Prepro VIP (81-122), human | / | Unkown | |
| HY-P2702 | Helodormin | Agonist | / | Unkown |
| HY-P3050 | Helospectin II | Inhibitor | / | Unkown |
| HY-P3053 | Helospectin I | / | Unkown | |
| HY-P4015 | VIP (1-12), human, porcine, rat, ovine | Ligand | / | Unkown |
| HY-RS03086 | CPAMD8 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS15653 | VIP Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-103019AR | (±)-Enitociclib (Standard) | / | Unkown | |
| HY-RS16586 | Vip Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23021 | Vip Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service